
|Videos|October 21, 2021
What keeps you up at night in ophthalmology: Part VIII
Author(s)David Hutton, Alex Delaney-Gesing
JD Schaub, chief operating officer at RVL Pharmaceuticals, shares what lingers on his mind in the ophthalmic field at the end of the day.
Advertisement
Watch the previous installments in this series:
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
STAAR Surgical terminates proposed acquisition by Alcon
2
Innovations in glaucoma poised for breakthrough in 2026 (and what might hold them back)
3
Rates of retinal layer thinning predict visual field progression in glaucoma
4
FDA grants Breakthrough Therapy Designation to Oculis’ privosegtor for optic neuritis
5









































